Brainstorm Cell Therapeutics Inc at Alliance for Regenerative Medicine Cell & Gene Meeting on the Mesa (Virtual) Transcript
Hi. I am Stacy Lindborg, Executive Vice President and Head of Global Clinical Research for BrainStorm Cell Therapeutics.
BrainStorm is a leader in developing innovative autologous cell therapies for highly debilitating neurodegenerative diseases. The origins of BrainStorm's cell therapeutic platform and the most advanced technology in our portfolio today is an autologous cellular therapy named NurOwn.
NurOwn is an autologous product, which means that we use each patient's own cells to produce their product. This patient is convenient, it's consistent, and it's reliable.
By convenient, as part of the manufacturing process, we cryopreserve NurOwn, which allows us to create an off-the-shelf product for each patient. One harvest of bone marrow creates several years of therapy. And from the point of harvesting each patient's bone marrow, which is a relatively simple outpatient procedure, the first treatment is available in 19 days with subsequent treatments being available in only seven days.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
